This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Edward Irvine, Ph.D
Postdoctoral Scientis at ETH Zürich, Sai Reddy Group
Speaker

Profile

Dr. Edward Irvine is a Postdoctoral Scientist at ETH Zurich in the laboratory of Prof. Sai Reddy. His research integrates immunology, protein engineering, and machine learning to develop novel platforms to predict and engineer immune function. Dr. Irvine completed his PhD in the Biological Sciences in Public Health at Harvard University, where he utilized computational immunology and antibody engineering strategies to investigate antibody-mediated control of Mycobacterium tuberculosis. His work has advanced our understanding of antibody Fc biology and how to program antibody function for therapeutic benefit.

Agenda Sessions

  • Generative Design of Antibody Fc-variants with Synthetic and Programmable Functional Profiles

    14:55